Frontal Sinus Squamous Cell Carcinoma in Dogs and Radiation Therapy Response
Author Information
Author(s): Loddo Pietro, Schiavo Luca, Dobson Jane, Marcinowska Ola
Primary Institution: Queen's Veterinary School Hospital, Cambridge University
Hypothesis
What is the clinical presentation and treatment response of dogs with primary frontal sinus squamous cell carcinoma (PFSSCC) to radiation therapy?
Conclusion
Radiation therapy may be a viable treatment option for dogs with PFSSCC, with some dogs showing significant survival times.
Supporting Evidence
- Six out of eight dogs showed a substantial reduction in tumor mass after radiation therapy.
- Three dogs achieved a complete response and survived for more than 17 months.
- The median survival time for all patients was 7.5 months.
Takeaway
This study looked at eight dogs with a rare type of cancer in their sinuses and found that radiation treatment helped some of them live longer.
Methodology
A retrospective observational study reviewing medical records of dogs diagnosed with PFSSCC, including their treatment and outcomes.
Potential Biases
Potential bias due to the retrospective nature of the study and variability in treatment protocols.
Limitations
The small sample size and lack of standardized treatment protocols limit the conclusions that can be drawn.
Participant Demographics
Dogs aged 5 to 12 years, including various breeds such as Jack Russell Terriers, Irish Water Spaniel, and Mastiff cross.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website